Fairfax Media network navigation

  • Home
  • Shares
  • Share details

AGENIX LIMITED (AGX)


Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Agenix Limited
Stock Code: AGX
Website: www.agenix.com
GICS Sub-Industry: Biotechnology
Market Cap ($M): 3
Equiv. Shares (M): 88

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 0.031 $ 0.030 $ 0.032 $ 0.030 $ 0.030 466,651 $ 0.001  3.333 %

Current Broker Consensus Recommendation more
Recommendation: Hold
Recommendation Date: 19th Dec 2008
12 Month Target Price (average): $0
Brokers Surveyed: 1

Company Overview

Business Description:
Agenix Limited (AGX) is an Australian based international biotechnology company with a wholly owned subsidiary in China. The Company’s lead program is ThromboView, a patented monoclonal antibody diagnostic that detects live blood clots in the human body. The Company is also developing AGX-1009, which is an antiviral medicine used to treat hepatitis B in China.

Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2012  A -1.4 -4.3 -- 0.0 0.0 0.0 --
2011  A -2.7 -9.7 -174.6 0.0 0.0 0.0 --
2010  A 2.5 13.0 -- 3.2 0.0 0.0 --
Source: Morningstar analyst estimates.

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F
Agenix (AGX) $2 M -- -- -- -- -- -- 0.0000 -- --
CSL (CSL) $30,092 M 0.0878 0.2981 0.1367 32.2743 24.8623 21.8733 0.0136 0.0173 0.0194
Mesoblast (MSB) $1,899 M -- -- -- -- -- -- 0.0000 0.0000 0.0000
Starpharma (SPL) $250 M -- -- -- -- -- -- 0.0000 0.0000 0.0000
Sirtex Medical (SRX) $601 M 0.4803 0.9033 0.3573 35.6623 18.7370 13.8042 0.0093 0.0178 0.0237

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
AGX -- -- 0.94 -- --
Market 1.07 12.6 0.89 2.31 2.58
Sector 0.93 20.3 2.40 0.54 7.03

Directors
Name Position Start Date
Mr Nicholas Weston Executive Chairman 22 August 2008
Mr Craig Graeme Chapman Non-Executive Director 21 May 2013
Mr Anthony Lee Vui Han Non-Executive Director 27 August 2007
Mr Christopher McNamara Non-Executive Director 21 February 2008

Management
Name Position
Gary Taylor Chief Financial Officer,Company Secretary

Substantial Shareholders
Holding Name
70,000,001 (8.33%) Tang Wen Seng
135,807,376 (16.17%) Annmac Investments Pty Ltd

Calendar of Events
Date Event
21 January 2014 Report (Interim)
05 September 2013 Report (Annual)
23 August 2013 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Trading Using Options and Minis

This guide to using options and MINIs to improve the results of your trading is for those with some experience in trading shares.

More details...

News

Commission questions high energy profits

The Age 24/05/2013 | The door has been opened to full deregulation of electricity prices in NSW after a report found there was a high degree of competition, with more than 60 per cent of households on unregulated contracts.

James Hardie posts 92% earnings fall

The Age 24/05/2013 | James Hardie expects no big improvement in the housing market this year but says the sector has stabilised after interest rate cuts.

Beer giant's local sales finally lift

The Age 24/05/2013 | Foster's owner SABMiller reported a 5 per cent drop in sales volumes in Australia over the past year but notched up 3 per cent growth in the fourth quarter, boosted in particular by the relaunch of Victoria Bitter.

ASIC takes exchange to task over computer glitch delays

The Age 24/05/2013 | The ASX took more than three hours to tell stockbrokers and investors a computer failure had knocked out its critical market announcements feed in October last year, according to a new investigation into the incident.

DuluxGroup pulls out of Masters

The Age 24/05/2013 | DuluxGroup has withdrawn its paint products from Masters and Danks stores to work more closely with other retailers.

Dollar in free fall as markets tumble

The Age 24/05/2013 | The Australian dollar plunged to its lowest level in a year, shedding over US2¢ in a session, as traders reacted to contradictory comments from the head of the US Federal Reserve on Thursday.

More...

Sponsored Links
Feedback Form